REGINA SCHMIDT: Open Payments
NPI 1013956044 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,984 in 101 payments from 13 companies in 2025. Trend: 2023 $1,018 · 2024 $1,234 · 2025 $1,984
Food & beverage: $1,984
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $608 |
| Janssen Biotech, Inc. | 14 | $370 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $162 |
| Aimmune Therapeutics, Inc. | 6 | $117 |
| Lilly USA, LLC | 5 | $104 |
| Ardelyx, Inc. | 5 | $103 |
| PFIZER INC. | 5 | $100 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 4 | $66 |
Products named: TREMFYA, RINVOQ, XIFAXAN, ENTYVIO, LINZESS, ZENPEP, CREON, OMVOH.
Industry payments across GA — which companies pay providers there.
